These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 23073661
41. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au. Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086 [Abstract] [Full Text] [Related]
47. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence. Hiremath S, Froeschl M, Ruzicka M. Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619 [Abstract] [Full Text] [Related]
48. Now That Renal Denervation Works, How Do We Proceed? Papademetriou V, Stavropoulos K, Doumas M, Tsioufis K. Circ Res; 2019 Mar; 124(5):693-695. PubMed ID: 30817252 [No Abstract] [Full Text] [Related]
51. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland. Bartuś K, Sadowski J, Kapelak B, Zajdel W, Godlewski J, Bartuś S, Bochenek M, Bartuś M, Żmudka K, Sobotka PA. Kardiol Pol; 2013 Mar; 71(2):152-8. PubMed ID: 23575708 [Abstract] [Full Text] [Related]
52. Current Status of Renal Denervation in Hypertension. Briasoulis A, Bakris GL. Curr Cardiol Rep; 2016 Nov; 18(11):107. PubMed ID: 27614466 [Abstract] [Full Text] [Related]
53. Renal sympathetic denervation: hypertension therapy and beyond. Williams PD, Whitbourn R. Expert Rev Med Devices; 2013 May; 10(3):329-38. PubMed ID: 23668705 [Abstract] [Full Text] [Related]
55. Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials. Stavropoulos K, Patoulias D, Imprialos K, Doumas M, Katsimardou A, Dimitriadis K, Tsioufis C, Papademetriou V. J Clin Hypertens (Greenwich); 2020 Apr; 22(4):572-584. PubMed ID: 32049436 [Abstract] [Full Text] [Related]
56. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Rosa J, Widimský P, Toušek P, Petrák O, Čurila K, Waldauf P, Bednář F, Zelinka T, Holaj R, Štrauch B, Šomlóová Z, Táborský M, Václavík J, Kociánová E, Branny M, Nykl I, Jiravský O, Widimský J. Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981 [Abstract] [Full Text] [Related]
59. [Renal denervation: new treatment for refractory hypertension?]. Argacha JF, Van de Borne P. Rev Med Brux; 2012 Sep 10; 33(4):292-4. PubMed ID: 23091934 [Abstract] [Full Text] [Related]
60. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension. Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P. J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]